Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes

Nature

Volumn 514, Issue 7521, 2014, Pages 237-241

  Wang, Xiaoting ^a   Ota, Naruhisa ^a   Manzanillo, Paolo ^a   Kates, Lance ^a   Zavala Solorio, Jose ^a   Eidenschenk, Celine ^a   Zhang, Juan ^a   Lesch, Justin ^a   Lee, Wyne P ^a   Ross, Jed ^a   Diehl, Lauri ^a   Van Bruggen, Nicholas ^a   Kolumam, Ganesh ^a   Ouyang, Wenjun ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN 23; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-22; INTERLEUKIN-22 RECEPTOR; LEPTIN RECEPTOR;

ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CITROBACTER RODENTIUM; COLON; DIABETES MELLITUS; DIET THERAPY; DRUG EFFECT; FEMALE; HYPERGLYCEMIA; IMMUNOLOGY; INFLAMMATION; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLIC DISORDER; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; MUCOSAL IMMUNITY; OBESITY; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; CITROBACTER RODENTIUM; COLON; DIABETES MELLITUS; DIET, HIGH-FAT; FEMALE; HYPERGLYCEMIA; IMMUNITY, MUCOSAL; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-23; INTERLEUKINS; LIPID METABOLISM; LIVER; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; RECEPTORS, INTERLEUKIN; RECEPTORS, LEPTIN;

EID: 84908311821     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13564     Document Type: Article

References (30)

1. Tremaroli, V. & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012).
2. Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
3. Gregor, M. F. & Hotamisligil, G. S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445 (2011).
4. Kanneganti, T. D. & Dixit, V. D. Immunological complications of obesity. Nature Immunol. 13, 707-712 (2012).
5. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
6. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A. & Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71-109 (2011).
7. Colonna, M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15-23 (2009).
8. Myers, M. G., Cowley, M. A. & Munzberg, H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 70, 537-556 (2008).
9. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
10. Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008).
11. Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321-1325 (2012).
12. Guo, X. et al. Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica. Mucosal Immunol. 4, 294-303 (2011).
13. + immune cells in spleen and mucosa. J. Immunol. 185, 1177-1185 (2010).
14. Procaccini, C., Jirillo, E. & Matarese, G. Leptin as an immunomodulator. Mol. Aspects Med. 33, 35-45 (2012).
15. Lord, G. M. et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901 (1998).
16. De Rosa, V. et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241-255 (2007).
17. + T cells promotes Th17 responses in systemic lupus erythematosus. J. Immunol. 190, 3054-3058 (2013).
18. Maaser, C. et al. Clearance of Citrobacter rodentium requires B cells but not secretory immunoglobulin A (IgA) or IgM antibodies. Infect. Immun. 72, 3315-3324 (2004).
19. Tilg, H. & Kaser, A. Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121, 2126-2132 (2011).
20. Han, M. S. et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 339, 218-222 (2013).
21. Uysal, K. T., Wiesbrock, S. M., Marino, M. W. & Hotamisligil, G. S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389, 610-614 (1997).
22. Ventre, J. et al. Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and nonobese mice. Diabetes 46, 1526-1531 (1997).
23. Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333-336 (2002).
24. 2-terminal kinase in adipose tissue protects against diet-induced obesity and improves insulin sensitivity in both liver and skeletal muscle in mice. Diabetes 60, 486-495 (2011).
25. 3-36 physiologically inhibits food intake. Nature 418, 650-654 (2002).
26. 3-36. N. Engl. J. Med. 349, 941-948 (2003).
27. Ortiz, A. A. et al. A novel long-acting selective neuropeptide Y2 receptor polyethylene glycol-conjugated peptide agonist reduces food intake and body weight and improves glucose metabolism in rodents. J. Pharmacol. Exp. Ther. 323, 692-700 (2007).
28. Yang, L. et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J. Hepatol. 53, 339-347 (2010).
29. Odegaard, J. I. et al. Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120 (2007).
30. Zechner, R.et al. Fat signals - lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 15, 279-291 (2012)